Does APREPITANT Cause Hyperammonaemic encephalopathy? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hyperammonaemic encephalopathy have been filed in association with APREPITANT (CINVANTI). This represents 0.2% of all adverse event reports for APREPITANT.
10
Reports of Hyperammonaemic encephalopathy with APREPITANT
0.2%
of all APREPITANT reports
0
Deaths
10
Hospitalizations
How Dangerous Is Hyperammonaemic encephalopathy From APREPITANT?
Of the 10 reports, 10 (100.0%) required hospitalization, and 8 (80.0%) were considered life-threatening.
Is Hyperammonaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Hyperammonaemic encephalopathy?
VALPROIC ACID (455)
FLUOROURACIL (156)
VALPROATE (120)
DIVALPROEX (119)
OXALIPLATIN (107)
TOPIRAMATE (101)
RISPERIDONE (96)
QUETIAPINE (91)
LEVETIRACETAM (71)
LEUCOVORIN (62)
Which APREPITANT Alternatives Have Lower Hyperammonaemic encephalopathy Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL